ALIVIO THERAPEUTICS

alivio-therapeutics-logo

Alivio Therapeutics is pioneering targeted disease immunomodulation as a novel strategy to treat a range of chronic and acute inflammatory disorders. Targeted disease immunomodulation involves tuning the immune system exclusively at the site of disease in the body, with minimal impact on the rest of the immune system. This long sought-after approach has potential to treat a range of chronic and acute inflammatory disorders including ones that would otherwise be difficult to treat. Alivio has exc... lusive rights to a proprietary inflammation-targeting technology, based on the research of Dr. Karp (BWH/HMS) and Dr. Robert Langer (MIT), which is the first technology to reproducibly show the ability to target immunomodulatory compounds to inflamed tissue, which can lead to dramatic improvements in treatment efficacy with major reductions in systemic effects. The platform has been validated in multiple labs and preclinical models of inflammation, including models where the inflammation occurred in different parts of the body (e.g., the GI system, the bladder, joints, skin, etc.). The technology could potentially be used with a variety of medications (e.g., small molecules, biologics, and nucleic acids) both independently or in combination, and is designed to be administered orally or via other routes. With this platform, Alivio aims to address the dozens of conditions where inflammation is a central part of the underlying disease pathology, but where targeted and effective treatment options are lacking.

#SimilarOrganizations #People #Financial #Website #More

ALIVIO THERAPEUTICS

Industry:
Biotechnology Health Care Medical

Founded:
2016-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.aliviotherapeutics.com

Total Employee:
11+

Status:
Active

Total Funding:
3.3 M USD

Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS OVH KnowBe4


Similar Organizations

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.


Current Advisors List

harry-leider_image

Harry Leider Board Member @ Alivio Therapeutics
Board_member
2020-01-01

Current Employees Featured

jeff-karp_image

Jeff Karp
Jeff Karp Co-Founder, Scientific Advisory Board Member, and Board Observer @ Alivio Therapeutics
Co-Founder, Scientific Advisory Board Member, and Board Observer
2016-05-01

Founder


jeff-karp_image

Jeff Karp

Investors List

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Alivio Therapeutics

Official Site Inspections

http://www.aliviotherapeutics.com

  • Host name: 172.67.202.124
  • IP address: 172.67.202.124
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Alivio Therapeutics" on Search Engine